This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hawtin, S. R. Articles by Wheatley, M. Search for Related Content PubMed PubMed Citation Articles by Hawtin, S. R. Articles by Wheatley, M.

The N-Terminal Juxtamembrane Segment of the V_1a Vasopressin Receptor Provides Two Independent Epitopes Required for High-Affinity Agonist Binding and Signaling

School of Biosciences, University of Birmingham, Birmingham B15 2TT, United Kingdom

Address all correspondence and requests for reprints to: Dr. Mark Wheatley, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom. E-mail: m.wheatley{at}bham.ac.uk.

It is fundamentally important to define how agonist-receptor interaction differs from antagonist-receptor interaction. The V_1a vasopressin receptor (V_1aR) is a member of the neurohypophysial hormone subfamily of G protein-coupled receptors. Using alanine-scanning mutagenesis of the N-terminal juxtamembrane segment of the V_1aR, we now establish that Glu⁵⁴ (1.35) is critical for arginine vasopressin binding. The mutant [E54A]V_1aR exhibited decreased arginine vasopressin affinity (1700-fold) and disrupted signaling, but antagonist binding was unaffected. Mutation of Glu⁵⁴ had an almost identical pharmacological effect as mutation of Arg⁴⁶, raising the possibility that agonist binding required a mutual interaction between Glu⁵⁴ and Arg⁴⁶. The role of these two charged residues was investigated by 1) substituting Glu⁵⁴; 2) inserting additional Glu/Arg in transmembrane helix (TM) 1; 3) repositioning the Glu/Arg in TM1; and 4) characterizing the reciprocal mutant [R46E/E54R]V_1aR. We conclude that 1) the positive/negative charges need to be precisely positioned in this N terminus/TM1 segment; and 2) Glu⁵⁴ and Arg⁴⁶ function independently, providing two discrete epitopes required for high-affinity agonist binding and signaling. This study explains why Glu and Arg, part of an -R(X₃)L/V(X₃)E(X₃)L- motif, are conserved at these loci throughout this G protein-coupled receptor subfamily and provides molecular insight into key differences between agonist and antagonist binding requirements.

This article has been cited by other articles:

				A. J. Stewart, R. Sellar, D. J. Wilson, R. P. Millar, and Z.-L. Lu Identification of a Novel Ligand Binding Residue Arg38(1.35) in the Human Gonadotropin-Releasing Hormone Receptor Mol. Pharmacol., January 1, 2008; 73(1): 75 - 81. [Abstract] [Full Text] [PDF]

				M. Conner, S. R. Hawtin, J. Simms, D. Wootten, Z. Lawson, A. C. Conner, R. A. Parslow, and M. Wheatley Systematic Analysis of the Entire Second Extracellular Loop of the V1a Vasopressin Receptor: KEY RESIDUES, CONSERVED THROUGHOUT A G-PROTEIN-COUPLED RECEPTOR FAMILY, IDENTIFIED J. Biol. Chem., June 15, 2007; 282(24): 17405 - 17412. [Abstract] [Full Text] [PDF]

				J. Rodrigo, A. Pena, B. Murat, M. Trueba, T. Durroux, G. Guillon, and D. Rognan Mapping the Binding Site of Arginine Vasopressin to V1a and V1b Vasopressin Receptors Mol. Endocrinol., February 1, 2007; 21(2): 512 - 523. [Abstract] [Full Text] [PDF]

				S. R. Hawtin, J. Simms, M. Conner, Z. Lawson, R. A. Parslow, J. Trim, A. Sheppard, and M. Wheatley Charged Extracellular Residues, Conserved throughout a G-protein-coupled Receptor Family, Are Required for Ligand Binding, Receptor Activation, and Cell-surface Expression J. Biol. Chem., December 15, 2006; 281(50): 38478 - 38488. [Abstract] [Full Text] [PDF]

				S. R. Hawtin Pharmacological Chaperone Activity of SR49059 to Functionally Recover Misfolded Mutations of the Vasopressin V1a Receptor J. Biol. Chem., May 26, 2006; 281(21): 14604 - 14614. [Abstract] [Full Text] [PDF]